Changyuan Yu
-
- Traditional Chinese Medicine Analysis 5
- Natural Compounds in Disease Treatment 4
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds 4
-
- Bladder and Urothelial Cancer Treatments 7
-
- Immune Cell Function and Interaction 6
-
- Natural product bioactivities and synthesis 5
-
- Nanoplatforms for cancer theranostics 4
-
- Nanomaterials for catalytic reactions 4
- Journals
- Advanced Functional Materials (1 paper)Chemical Communications (1 paper)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Changyuan Yu
58 papers receiving 817 citations
Peers
Comparison fields: 5 of 109
- Complementary and alternative medicine 123
- Pharmacology 61
- Biochemistry 40
- Biomaterials 80
- Biological Psychiatry 15
Countries citing papers authored by Changyuan Yu
This map shows the geographic impact of Changyuan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyuan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyuan Yu more than expected).
Fields of papers citing papers by Changyuan Yu
This network shows the impact of papers produced by Changyuan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyuan Yu. The network helps show where Changyuan Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Changyuan Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 0 | |
| 12 | 2022 | 47 | |
| 13 | 2022 | 21 | |
| 14 | 2021 | 22 | |
| 15 | 2021 | 4 | |
| 16 | 2021 | 33 | |
| 17 | 2020 | 10 | |
| 18 | 2019 | 7 | |
| 19 | 2016 | 21 | |
| 20 | Immunoregulation Function of Glycyrrhizae Radix et Rhizoma Polysaccharide to γδT Cells from Human Peripheral Blood | 2013 | 3 |
About Changyuan Yu
Changyuan Yu is a scholar working on Complementary and alternative medicine, Pharmacology and Toxicology, having authored 63 papers that have together received 830 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Immune Cell Function and Interaction (6 papers), Traditional Chinese Medicine Analysis (5 papers), Natural product bioactivities and synthesis (5 papers), Pharmacological Effects of Natural Compounds (4 papers), Nanoplatforms for cancer theranostics (4 papers), Natural Compounds in Disease Treatment (4 papers) and Nanomaterials for catalytic reactions (4 papers). The work is most often cited by research in Complementary and alternative medicine (123 citations), Pharmacology (61 citations) and Biochemistry (40 citations). Changyuan Yu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yixin Wu, Gang Cheng, Zhao Yang, Seema Singh, Zhong‐Mei Zou, Yuxin Xie, Maolin Wang, Aiping Lü, Guang Chen and Nan Zhang. Their work appears in journals such as Advanced Functional Materials, Chemical Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.